MG
Metagenomi, Inc. Common Stock
MGX · NASDAQ
$1.10 -1.79% (-$0.02)
1M -10.57%
Market Cap $42.5M
P/E Ratio -
Div. Yield -
ROE 63.65%
Piotroski F-Score Weak
2/9Valuation
78 /100
Cheap P/S 3.14x
P/B 0.38x
P/E N/A
Growth
82 /100
Growing Rev. growth 13.59%
EPS growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Gross margin 74.29%
FCF margin 632.67%
Net margin 689.20%
Quality
1 /100
Poor ROIC 65.88%
Asset turnover 0.08x
ROE 63.65%
Debt
98 /100
Low Debt/Equity 0.34x
Current ratio 4.50x
Int. coverage N/A
Stability
48 /100
Moderate Beta 0.68x
Profitable years 0
Rev. volatility 108.17%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na MGX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jian Irish
Employees
113
Headquarters
Emeryville
Nadcházející události
10 LIS
Earnings
Upcoming earnings report